XtremisBio Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

XtremisBio General Information

Description

Developer of targeted RAS (rat sarcoma) cancer therapy designed to treat advanced cancers driven by KRAS (Kirsten rat sarcoma viral oncogene homolog) mutations using a downregulation mechanism. The company offers a proprietary drug focused on disrupting RAS signaling pathways to selectively kill cancer cells, enabling healthcare providers to overcome treatment resistance and improve outcomes for patients with hard-to-treat tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Seattle, WA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Seattle, WA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XtremisBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view XtremisBio’s complete valuation and funding history, request access »

XtremisBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
3rdEyeBio Accelerator/Incubator Minority
To view XtremisBio’s complete investors history, request access »

XtremisBio FAQs

  • Where is XtremisBio headquartered?

    XtremisBio is headquartered in Seattle, WA.

  • What industry is XtremisBio in?

    XtremisBio’s primary industry is Drug Discovery.

  • Is XtremisBio a private or public company?

    XtremisBio is a Private company.

  • What is XtremisBio’s current revenue?

    The current revenue for XtremisBio is .

  • Who are XtremisBio’s investors?

    3rdEyeBio has invested in XtremisBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process